Логин: Пароль: ?
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное


Наши партнеры:



A brief analysis of the CBD market for goods used for industrial purposes in the EU


In February 2019, the European Parliament voted in favor of a resolution aimed at supporting the possibility of using drug-free cannabinoids for industrial purposes in the countries of the EU . In April, a decision was made according to which the content of THC in CBD products should not exceed 0.3% instead of the value that is currently valid at 0.2% (this norm will come into force in 2021).

On the pages of the profile electronic publication of Ukrainian hemp breeders, more than once attention was focused on an extremely cost-effective product market, the formulation of which includes drug-free cannabinoids used for industrial purposes . Given the fact that in our country this kind of legal framework regulating the possibility of beznarkoticheskih cannabis for industrial purposes only created , publication editors asked our colleagues from information and analytical site Hemp Consulting with a request to clarify what is the situation on this market , the existing currently in the territoryEuropean Union . Considering the fact that Hemp Consulting specialists are actively working on creating a draft regulatory acts that can regulate the possibilities for the use of drug-free cannabinoids for non-medical purposes in Ukraine , information and analysis has been collected and systematized on how the production capabilities are regulated from the experts of the information and analytical platform , sales and use of products , part of which includes beznarkoticheskie cannabinoids almost in all economically developed countries , experts of the above structure agreed tezisno share information , they use to prepare the appropriate legal act in Ukraine .

Beznarkoticheskie cannabinoids and especially cannabidiol (CBD) has become a popular product around the world due to its medicinal properties . At the moment, they are universally used for industrial purposes , as tasty and extremely healthy food ingredients , exclusive raw materials for the production of cosmetics , biologically active , food and feed additives . Due to the rapid growth in the use of drug-free cannabinoids, governments of economically developed countries are everywhere faced with the need to regulate their use . 

In the EU, there are regulatory documents governing the possibility of using drug-free cannabinoids for industrial purposes . However, in addition to certain restrictions imposed on this type of activity by EU legal acts , there are national rules that improve or worsen the ability to use products, which include non-drug cannabinoids used for non-medical purposes in individual EU countries .

In January 2019, the European Commission decided to revise the requirements for new food products in order to clarify the rules regarding drug-free cannabinoids . Currently individual products , made from hemp , are no longer considered "new food ", for example, this concerns seed , as well as their derivatives ( oil , meal , dehulled seeds , hemp protein and etc .). These rules apply only in cases where the amount of tetrahydrocannabinol in the dried straw of plants does not exceed 0.2%. Extracts of non-drug cannabinoids , including cannabidiol , are currently classified as “new food products ”, and their manufacture and sales are regulated by a special EU directive . This means that manufacturers of food and beverage products that include cannabinoid extracts must comply with special rules governed by the above - mentioned legal act of the European Union . Despite the certain restrictions imposed in various EU countries on hemp products, the formulation of which includes drug-free cannabinoids , it is quite easy to find food and drinks in the countries of the European Union that include, for example, cannabidiol . On the one hand, their sale is not regulated, on the other hand, it is not prosecuted by local law enforcement or regulatory authorities.  

Analyzing the European market for products containing non-drug cannabinoids, it can be argued that cannabidiol of plant origin is legal for sales in almost all countries within the EU , with the exception of Slovakia. At the moment, if a person is in the territory of the European Union , he can legally purchase , use non-medical products , which include drug-free cannabinoids . However, in various EU countries, internal regulatory acts add to the confusion and ambiguous attitude of law enforcement agencies and regulatory authorities to various kinds of products, which include drug-free cannabinoids . This leads, for example, to the fact that if CBD oil may be included in the recipe almost every product , the individual self CBD oil EU countries on the territory of their states consider illegal product or normative legal acts of the legality of this category of goods is not regulated (located in gray area of ​​the law). 


At the moment , the country is legal to sell food , cosmetics , biologically active and feed additives , the composition of which includes a significant amount of drug-free cannabinoids (primarily cannabidiol ) and trace amounts of tetrahydrocannabinol (THC). In the event that the above headings comply with several rules , they may contain any number of leaves and inflorescences of technical hemp of a therapeutic orientation :

- the product should not be positioned as a therapeutic agent;

- the level of THC in the product should not exceed 0.05%;

- the buyer should not be offered to use products that include more than 160 milligrams of cannabidiol for use per day;

- in the event that the heading belongs to the category of food products , appropriate documentation must be present indicating that these products are allowed for sale by the relevant government agencies responsible for the quality and safety of food products .

In the Netherlands, it is illegal to sell extracts of individual cannabinoids to the public. Herbal cannabidiol is a legitimate product on the market , but an isolate containing a significant amount of a huge amount of therapeutically active substances is illegal for sale . The absurdity of the situation is that Dutch companies can legally produce both extracts and isolates, but the problem is that its sale is not regulated at the level of regulatory legal acts . 


At the level of legal acts in Spain, production , sales , and the purchase of various types of goods containing non-drug cannabinoids (primarily cannabidiol ) are regulated . However, there is a nuance that severely limits the possibilities of using food products containing cannabidiol . In Spain, the Agency for Medicines and Medical Devices (Agencia Española de Medicamentos y Productos Sanitarios, AEMPS) is responsible for regulating the quality of food and food additives . AEMPS departmental documents do not indicate cannabidiol as an ingredient that is safe for human consumption. This means that it is forbidden to sell products containing cannabidiol as a product that can be swallowed ( food , food or biologically active additives ) in Spain .


Despite the fact that France is the largest producer of technical hemp in the entire European Union , CBD products in the country are available only if it follows certain restrictions. In 2018, the French government introduced strict rules on CBD oil, according to which CBD oil should not even contain trace amounts of THC, and the above oil can be produced from hemp raw materials , in the dried green mass of which the amount of THC should not exceed a level of 0, 2% In addition, CBD oil is illegal in the country if it is produced for personal use.


Government officials of the country as a whole adhere to all the rules in respect of products not medical use , containing in its composition cannabidiol , which are prescribed by regulations of the EU . There are no additional restrictions on the various categories of products containing drug-free cannabinoids . The above thesis means that any products whose content of tetrahydrocannabinol exceeds 0.3% are illegal in Austria , the rest of the products containing drug-free cannabinoids in their composition are allowed on the market . In addition, on the territory of the country not only the cultivation of industrial crops of technical hemp is allowed , but also the possibility of using leaves and inflorescences of non-cannabis plant varieties of therapeutic orientation for industrial purposes is regulated .


In the country , the Federal Institute for Medicines and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) is responsible for determining the legality of finding products containing cannabidiol on the market . Currently, BfArM employees have strictly regulated the possibility of using hemp for medical and industrial purposes . In Germany , hemp products are allowed for distribution and sale, used for industrial purposes only those obtained from EU- certified seeds , the amount of THC in dried dry straw of which does not exceed 0.2%. According to the published BfArM guidelines, end consumers can only buy hemp extracts made from industrial hemp . This rule applies only to non-medical products . 

United Kingdom

The country allows sales and the use of CBD products that do not contain tetrahydrocannabinol in their composition. In the event that the product contains at least a trace amount of THC, this product is controlled - i.e. such, acquisition, storage, the use of which involves liability provided for by applicable law . Despite the foregoing, experts from the English hemp market claim that the number of consumers of non-medical commodity items ( food , cosmetics , biologically active or food additives ) in the country is growing exponentially every year . For example, according to the Cannabis Trades Association UK, if in 2017 there were about 125 thousand consumers of various categories of non-medical cannabinoid products in the country , then in 2018 there were about 250 thousand people.


The current regulatory framework of the country does not sufficiently regulate the possibility of using CBD for non-medical products , which leads to the fact that this highly liquid market is in the “gray” zone of law.


It became the first country in the EU to allow the free sale of products that include cannabidiol in May 2019. The Food Safety Agency and the Ministry of Agriculture, Food and Forestry of Bulgaria issued a certificate of free sale of CBD products manufactured by Kannaway (a subsidiary of Medical Marijuana Inc). According to the permits issued, products containing cannabidiol can now also be used for export sales . 

In the Czech Republic and Switzerland, entrepreneurs are allowed to sell cannabinoid isolate directly to the public.

The highlight of the CBD market for products used in the EU for industrial purposes

In February 2019, the European Parliament voted in favor of a resolution aimed at supporting the possibility of using drug-free cannabinoids for industrial purposes in the countries of the 

Обучение в рамках "Конопляного Университета"

Все объявления »